ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,296,000 | -92.7% | 71,142 | -96.1% | 0.01% | -93.2% |
| Q1 2019 | $44,938,000 | +124.0% | 1,843,220 | +30.9% | 0.18% | +93.4% |
| Q4 2018 | $20,065,000 | +385.0% | 1,408,073 | +417.3% | 0.09% | +468.8% |
| Q3 2018 | $4,137,000 | -12.2% | 272,177 | -3.0% | 0.02% | -20.0% |
| Q2 2018 | $4,710,000 | +72.8% | 280,671 | +68.0% | 0.02% | +53.8% |
| Q1 2018 | $2,726,000 | – | 167,035 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |